glp 1 not working Outpatient Sedation Basics for Patients on GLP-1 Medications GLP-1 nonresponders: Up to 1
Description
Its main risk is renal stones, and most of its side effectscognitive problems, imbalance, and paresthesiasare dose related
GIP receptor agonism attenuates GLP-1 receptor agonistinduced nausea and emesis in preclinical models
However, outcomes for the two groups were similar
Several studies have identified an association between semaglutide use and a higher incidence of NAION, although researchers continue to examine the biological mechanisms involved and whether other patient-specific risk factors contribute to the condition
Wiener BG, Gnirke M, Vassallo S, Smith SW, Su MK
